Considering the lack of direct evidence linking MBZ’s effects on Girdin to Akt and NF-κB signaling, we designed experiments to elucidate MBZ’s anticancer mechanisms in ovarian cancer (OC) cell lines (OVCAR3 and OAW42). This evidence concerns the gene AKT1 and ovarian carcinoma.